Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Clinical trial NCT03634982 · UNKNOWN
Trial details
- NCT number
- NCT03634982
- Sponsor
- Revolution Medicines, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-28
- Primary completion
- 2023-03-31
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.